database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,12 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,24 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,36 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Cancer,Solid Cancer,145,165,12 months,6,3.6363636364
MPCD,DMARD,Cancer,Solid Cancer,145,165,24 months,8,4.8484848485
MPCD,DMARD,Cancer,Solid Cancer,145,165,36 months,8,4.8484848485
MPCD,DMARD,Cancer,Solid Cancer,145,165,AS cohort entry to exposure,5,3.0303030303
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,12 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,24 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,36 months,2,1.2121212121
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,AS cohort entry to exposure,0,0
MPCD,DMARD,Infection,Hospitalized infection,145,165,12 months,2,1.2121212121
MPCD,DMARD,Infection,Hospitalized infection,145,165,24 months,5,3.0303030303
MPCD,DMARD,Infection,Hospitalized infection,145,165,36 months,7,4.2424242424
MPCD,DMARD,Infection,Hospitalized infection,145,165,AS cohort entry to exposure,3,1.8181818182
MPCD,DMARD,Infection,Opportunistic infection,145,165,12 months,1,0.6060606061
MPCD,DMARD,Infection,Opportunistic infection,145,165,24 months,4,2.4242424242
MPCD,DMARD,Infection,Opportunistic infection,145,165,36 months,8,4.8484848485
MPCD,DMARD,Infection,Opportunistic infection,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,12 months,7,4.2424242424
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,24 months,9,5.4545454545
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,36 months,9,5.4545454545
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,AS cohort entry to exposure,7,4.2424242424
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,12 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,24 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,36 months,4,2.4242424242
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,AS cohort entry to exposure,2,1.2121212121
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,12 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,24 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,36 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,12 months,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,24 months,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,36 months,1,0.6060606061
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,AS cohort entry to exposure,0,0
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,12 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,24 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,36 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,12 months,2,1.2121212121
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,24 months,4,2.4242424242
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,36 months,6,3.6363636364
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,12 months,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,24 months,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,36 months,5,3.0303030303
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,AS cohort entry to exposure,3,1.8181818182
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,12 months,5,3.0303030303
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,24 months,7,4.2424242424
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,36 months,8,4.8484848485
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,AS cohort entry to exposure,5,3.0303030303
MPCD,DMARD,Uveitis,Uveitis,145,165,12 months,11,6.6666666667
MPCD,DMARD,Uveitis,Uveitis,145,165,24 months,13,7.8787878788
MPCD,DMARD,Uveitis,Uveitis,145,165,36 months,14,8.4848484848
MPCD,DMARD,Uveitis,Uveitis,145,165,AS cohort entry to exposure,10,6.0606060606
MPCD,NSAID,Cancer,Solid Cancer,265,355,12 months,7,1.9718309859
MPCD,NSAID,Cancer,Solid Cancer,265,355,24 months,10,2.8169014085
MPCD,NSAID,Cancer,Solid Cancer,265,355,36 months,11,3.0985915493
MPCD,NSAID,Cancer,Solid Cancer,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,12 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,24 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,36 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,AS cohort entry to exposure,0,0
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,12 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,24 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,36 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,12 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,24 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,36 months,1,0.2816901408
MPCD,NSAID,Infection,Hospitalized infection,265,355,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,12 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,24 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,36 months,0,0
MPCD,NSAID,Infection,Opportunistic infection,265,355,AS cohort entry to exposure,2,0.5633802817
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,12 months,4,1.1267605634
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,24 months,6,1.6901408451
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,36 months,7,1.9718309859
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,AS cohort entry to exposure,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,12 months,4,1.1267605634
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,24 months,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,36 months,5,1.4084507042
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,AS cohort entry to exposure,6,1.6901408451
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,12 months,1,0.2816901408
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,24 months,2,0.5633802817
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,36 months,2,0.5633802817
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,12 months,4,1.1267605634
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,24 months,7,1.9718309859
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,36 months,9,2.5352112676
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,12 months,2,0.5633802817
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,24 months,3,0.8450704225
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,36 months,3,0.8450704225
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,12 months,9,2.5352112676
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,24 months,10,2.8169014085
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,36 months,11,3.0985915493
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,12 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,24 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,36 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,12 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,24 months,3,0.8450704225
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,36 months,4,1.1267605634
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,Uveitis,Uveitis,265,355,12 months,27,7.6056338028
MPCD,NSAID,Uveitis,Uveitis,265,355,24 months,31,8.7323943662
MPCD,NSAID,Uveitis,Uveitis,265,355,36 months,31,8.7323943662
MPCD,NSAID,Uveitis,Uveitis,265,355,AS cohort entry to exposure,24,6.7605633803
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,12 months,2,0.390625
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,24 months,3,0.5859375
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,36 months,5,0.9765625
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Cancer,Solid Cancer,512,512,12 months,27,5.2734375
MPCD,No exposure,Cancer,Solid Cancer,512,512,24 months,38,7.421875
MPCD,No exposure,Cancer,Solid Cancer,512,512,36 months,45,8.7890625
MPCD,No exposure,Cancer,Solid Cancer,512,512,AS cohort entry to exposure,4,0.78125
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,12 months,13,2.5390625
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,24 months,15,2.9296875
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,36 months,18,3.515625
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,12 months,5,0.9765625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,24 months,8,1.5625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,36 months,8,1.5625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,12 months,1,0.1953125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,24 months,4,0.78125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,36 months,4,0.78125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Hospitalized infection,512,512,12 months,5,0.9765625
MPCD,No exposure,Infection,Hospitalized infection,512,512,24 months,13,2.5390625
MPCD,No exposure,Infection,Hospitalized infection,512,512,36 months,16,3.125
MPCD,No exposure,Infection,Hospitalized infection,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Opportunistic infection,512,512,12 months,2,0.390625
MPCD,No exposure,Infection,Opportunistic infection,512,512,24 months,4,0.78125
MPCD,No exposure,Infection,Opportunistic infection,512,512,36 months,6,1.171875
MPCD,No exposure,Infection,Opportunistic infection,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,12 months,14,2.734375
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,24 months,19,3.7109375
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,36 months,23,4.4921875
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,AS cohort entry to exposure,3,0.5859375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,12 months,8,1.5625
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,24 months,10,1.953125
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,36 months,12,2.34375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,12 months,1,0.1953125
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,24 months,2,0.390625
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,36 months,3,0.5859375
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,24 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,36 months,2,0.390625
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,24 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,36 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,12 months,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,24 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,36 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,12 months,9,1.7578125
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,24 months,11,2.1484375
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,36 months,12,2.34375
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,12 months,1,0.1953125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,24 months,2,0.390625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,36 months,2,0.390625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,12 months,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,24 months,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,36 months,1,0.1953125
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,12 months,11,2.1484375
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,24 months,15,2.9296875
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,36 months,16,3.125
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,12 months,14,2.734375
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,24 months,25,4.8828125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,36 months,26,5.078125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,AS cohort entry to exposure,2,0.390625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,12 months,10,1.953125
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,24 months,13,2.5390625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,36 months,14,2.734375
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,AS cohort entry to exposure,3,0.5859375
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,12 months,15,2.9296875
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,24 months,18,3.515625
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,36 months,22,4.296875
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,AS cohort entry to exposure,6,1.171875
MPCD,No exposure,Uveitis,Uveitis,512,512,12 months,40,7.8125
MPCD,No exposure,Uveitis,Uveitis,512,512,24 months,53,10.3515625
MPCD,No exposure,Uveitis,Uveitis,512,512,36 months,54,10.546875
MPCD,No exposure,Uveitis,Uveitis,512,512,AS cohort entry to exposure,9,1.7578125
MPCD,TNF,Cancer,Hematologic Cancer,575,670,12 months,1,0.1492537313
MPCD,TNF,Cancer,Hematologic Cancer,575,670,24 months,2,0.2985074627
MPCD,TNF,Cancer,Hematologic Cancer,575,670,36 months,2,0.2985074627
MPCD,TNF,Cancer,Hematologic Cancer,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Cancer,Solid Cancer,575,670,12 months,15,2.2388059701
MPCD,TNF,Cancer,Solid Cancer,575,670,24 months,21,3.1343283582
MPCD,TNF,Cancer,Solid Cancer,575,670,36 months,23,3.4328358209
MPCD,TNF,Cancer,Solid Cancer,575,670,AS cohort entry to exposure,12,1.7910447761
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,12 months,13,1.9402985075
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,24 months,15,2.2388059701
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,36 months,15,2.2388059701
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,AS cohort entry to exposure,10,1.4925373134
MPCD,TNF,Cardiac disease,Conduction Block,575,670,12 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,24 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,36 months,1,0.1492537313
MPCD,TNF,Cardiac disease,Conduction Block,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,12 months,0,0
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,24 months,2,0.2985074627
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,36 months,2,0.2985074627
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Infection,Hospitalized infection,575,670,12 months,4,0.5970149254
MPCD,TNF,Infection,Hospitalized infection,575,670,24 months,7,1.0447761194
MPCD,TNF,Infection,Hospitalized infection,575,670,36 months,9,1.3432835821
MPCD,TNF,Infection,Hospitalized infection,575,670,AS cohort entry to exposure,4,0.5970149254
MPCD,TNF,Infection,Opportunistic infection,575,670,12 months,6,0.8955223881
MPCD,TNF,Infection,Opportunistic infection,575,670,24 months,10,1.4925373134
MPCD,TNF,Infection,Opportunistic infection,575,670,36 months,11,1.6417910448
MPCD,TNF,Infection,Opportunistic infection,575,670,AS cohort entry to exposure,2,0.2985074627
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,12 months,34,5.0746268657
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,24 months,38,5.671641791
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,36 months,41,6.1194029851
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,AS cohort entry to exposure,28,4.1791044776
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,12 months,16,2.3880597015
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,24 months,18,2.6865671642
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,36 months,18,2.6865671642
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,AS cohort entry to exposure,15,2.2388059701
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,12 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,24 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,36 months,2,0.2985074627
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,12 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,24 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,36 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,12 months,4,0.5970149254
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,24 months,7,1.0447761194
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,36 months,8,1.1940298507
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,AS cohort entry to exposure,4,0.5970149254
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,12 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,24 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,36 months,1,0.1492537313
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,12 months,9,1.3432835821
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,24 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,36 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,12 months,11,1.6417910448
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,24 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,36 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,PsO/PsA,Psoriasis,575,670,12 months,24,3.5820895522
MPCD,TNF,PsO/PsA,Psoriasis,575,670,24 months,30,4.4776119403
MPCD,TNF,PsO/PsA,Psoriasis,575,670,36 months,31,4.6268656716
MPCD,TNF,PsO/PsA,Psoriasis,575,670,AS cohort entry to exposure,15,2.2388059701
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,12 months,36,5.3731343284
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,24 months,46,6.8656716418
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,36 months,50,7.4626865672
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,AS cohort entry to exposure,31,4.6268656716
MPCD,TNF,Uveitis,Uveitis,575,670,12 months,56,8.3582089552
MPCD,TNF,Uveitis,Uveitis,575,670,24 months,62,9.2537313433
MPCD,TNF,Uveitis,Uveitis,575,670,36 months,64,9.552238806
MPCD,TNF,Uveitis,Uveitis,575,670,AS cohort entry to exposure,45,6.7164179104
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,12 months,6,0.7722007722
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,24 months,7,0.9009009009
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,36 months,7,0.9009009009
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,AS cohort entry to exposure,4,0.5148005148
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,12 months,4,0.5148005148
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,24 months,11,1.4157014157
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,36 months,14,1.8018018018
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,AS cohort entry to exposure,5,0.6435006435
Marketscan,DMARD,Cancer,Solid Cancer,710,777,12 months,41,5.2767052767
Marketscan,DMARD,Cancer,Solid Cancer,710,777,24 months,43,5.5341055341
Marketscan,DMARD,Cancer,Solid Cancer,710,777,36 months,48,6.1776061776
Marketscan,DMARD,Cancer,Solid Cancer,710,777,AS cohort entry to exposure,35,4.5045045045
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,12 months,7,0.9009009009
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,24 months,11,1.4157014157
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,36 months,15,1.9305019305
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,AS cohort entry to exposure,6,0.7722007722
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,12 months,8,1.0296010296
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,24 months,14,1.8018018018
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,36 months,14,1.8018018018
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,12 months,0,0
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,24 months,1,0.1287001287
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,36 months,2,0.2574002574
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Infection,Hospitalized infection,710,777,12 months,26,3.3462033462
Marketscan,DMARD,Infection,Hospitalized infection,710,777,24 months,39,5.0193050193
Marketscan,DMARD,Infection,Hospitalized infection,710,777,36 months,42,5.4054054054
Marketscan,DMARD,Infection,Hospitalized infection,710,777,AS cohort entry to exposure,22,2.8314028314
Marketscan,DMARD,Infection,Opportunistic infection,710,777,12 months,11,1.4157014157
Marketscan,DMARD,Infection,Opportunistic infection,710,777,24 months,17,2.1879021879
Marketscan,DMARD,Infection,Opportunistic infection,710,777,36 months,20,2.574002574
Marketscan,DMARD,Infection,Opportunistic infection,710,777,AS cohort entry to exposure,9,1.1583011583
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,12 months,31,3.9897039897
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,24 months,33,4.2471042471
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,36 months,35,4.5045045045
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,AS cohort entry to exposure,24,3.0888030888
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,12 months,12,1.5444015444
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,24 months,16,2.0592020592
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,36 months,18,2.3166023166
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,AS cohort entry to exposure,5,0.6435006435
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,12 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,24 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,36 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,12 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,24 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,36 months,2,0.2574002574
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,12 months,5,0.6435006435
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,24 months,10,1.287001287
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,36 months,16,2.0592020592
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,12 months,2,0.2574002574
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,24 months,2,0.2574002574
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,36 months,3,0.3861003861
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,12 months,5,0.6435006435
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,24 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,36 months,8,1.0296010296
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,AS cohort entry to exposure,3,0.3861003861
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,12 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,24 months,12,1.5444015444
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,36 months,15,1.9305019305
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,12 months,26,3.3462033462
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,24 months,33,4.2471042471
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,36 months,37,4.7619047619
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,AS cohort entry to exposure,22,2.8314028314
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,12 months,46,5.9202059202
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,24 months,53,6.8211068211
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,36 months,54,6.9498069498
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,AS cohort entry to exposure,29,3.7323037323
Marketscan,DMARD,Uveitis,Uveitis,710,777,12 months,56,7.2072072072
Marketscan,DMARD,Uveitis,Uveitis,710,777,24 months,69,8.8803088803
Marketscan,DMARD,Uveitis,Uveitis,710,777,36 months,74,9.5238095238
Marketscan,DMARD,Uveitis,Uveitis,710,777,AS cohort entry to exposure,46,5.9202059202
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,12 months,4,0.230813618
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,24 months,7,0.4039238315
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,36 months,7,0.4039238315
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,AS cohort entry to exposure,7,0.4039238315
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,12 months,11,0.6347374495
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,24 months,19,1.0963646855
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,36 months,21,1.2117714945
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,AS cohort entry to exposure,18,1.038661281
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,12 months,63,3.6353144836
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,24 months,83,4.7893825736
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,36 months,87,5.0201961916
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,AS cohort entry to exposure,62,3.5776110791
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,12 months,8,0.461627236
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,24 months,12,0.692440854
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,36 months,12,0.692440854
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,AS cohort entry to exposure,10,0.577034045
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,12 months,22,1.269474899
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,24 months,29,1.6733987305
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,36 months,34,1.961915753
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,AS cohort entry to exposure,16,0.923254472
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,12 months,2,0.115406809
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,24 months,5,0.2885170225
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,36 months,7,0.4039238315
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,AS cohort entry to exposure,4,0.230813618
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,12 months,48,2.769763416
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,24 months,65,3.7507212926
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,36 months,75,4.3277553376
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,AS cohort entry to exposure,59,3.4045008656
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,12 months,14,0.807847663
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,24 months,20,1.15406809
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,36 months,24,1.384881708
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,AS cohort entry to exposure,14,0.807847663
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,12 months,41,2.3658395845
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,24 months,48,2.769763416
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,36 months,53,3.0582804385
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,AS cohort entry to exposure,44,2.538949798
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,12 months,26,1.500288517
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,24 months,29,1.6733987305
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,36 months,33,1.9042123485
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,AS cohort entry to exposure,19,1.0963646855
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,12 months,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,24 months,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,36 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,12 months,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,24 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,36 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,12 months,1,0.0577034045
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,24 months,2,0.115406809
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,36 months,2,0.115406809
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,AS cohort entry to exposure,2,0.115406809
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,12 months,10,0.577034045
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,24 months,13,0.7501442585
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,36 months,16,0.923254472
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,AS cohort entry to exposure,13,0.7501442585
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,12 months,7,0.4039238315
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,24 months,13,0.7501442585
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,36 months,14,0.807847663
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,AS cohort entry to exposure,2,0.115406809
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,12 months,18,1.038661281
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,24 months,21,1.2117714945
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,36 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,AS cohort entry to exposure,9,0.5193306405
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,12 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,24 months,31,1.7888055395
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,36 months,36,2.077322562
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,AS cohort entry to exposure,26,1.500288517
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,12 months,42,2.423542989
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,24 months,55,3.1736872475
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,36 months,63,3.6353144836
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,AS cohort entry to exposure,40,2.30813618
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,12 months,38,2.192729371
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,24 months,41,2.3658395845
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,36 months,44,2.538949798
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,AS cohort entry to exposure,48,2.769763416
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,12 months,124,7.1552221581
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,24 months,159,9.1748413156
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,36 months,165,9.5210617426
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,AS cohort entry to exposure,130,7.5014425851
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,12 months,8,0.4708652148
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,24 months,9,0.5297233667
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,36 months,11,0.6474396704
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,12 months,15,0.8828722778
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,24 months,20,1.1771630371
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,36 months,22,1.2948793408
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,12 months,45,2.6486168334
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,24 months,60,3.5314891112
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,36 months,66,3.8846380224
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,12 months,23,1.3537374926
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,24 months,28,1.6480282519
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,36 months,30,1.7657445556
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,AS cohort entry to exposure,3,0.1765744556
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,12 months,23,1.3537374926
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,24 months,32,1.8834608593
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,36 months,36,2.1188934667
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,24 months,5,0.2942907593
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,36 months,6,0.3531489111
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,12 months,36,2.1188934667
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,24 months,62,3.6492054149
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,36 months,74,4.3555032372
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,12 months,10,0.5885815185
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,24 months,14,0.824014126
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,36 months,17,1.0005885815
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,12 months,52,3.0606238964
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,24 months,68,4.0023543261
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,36 months,74,4.3555032372
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,AS cohort entry to exposure,13,0.7651559741
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,12 months,43,2.5309005297
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,24 months,56,3.2960565038
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,36 months,58,3.4137728075
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,AS cohort entry to exposure,7,0.412007063
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,24 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,36 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,12 months,3,0.1765744556
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,24 months,4,0.2354326074
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,36 months,4,0.2354326074
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,12 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,12 months,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,24 months,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,36 months,1,0.0588581519
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,12 months,16,0.9417304297
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,24 months,23,1.3537374926
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,36 months,28,1.6480282519
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,12 months,0,0
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,24 months,3,0.1765744556
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,36 months,4,0.2354326074
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,12 months,14,0.824014126
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,24 months,23,1.3537374926
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,36 months,26,1.5303119482
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,12 months,19,1.1183048852
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,24 months,30,1.7657445556
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,36 months,36,2.1188934667
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,12 months,50,2.9429075927
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,24 months,58,3.4137728075
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,36 months,61,3.5903472631
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,AS cohort entry to exposure,13,0.7651559741
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,12 months,45,2.6486168334
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,24 months,57,3.3549146557
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,36 months,62,3.6492054149
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,AS cohort entry to exposure,18,1.0594467334
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,12 months,165,9.7115950559
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,24 months,197,11.595055915
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,36 months,209,12.301353737
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,AS cohort entry to exposure,41,2.413184226
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,12 months,2,0.0579206487
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,24 months,8,0.2316825948
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,36 months,8,0.2316825948
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,12 months,18,0.5212858384
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,24 months,40,1.1584129742
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,36 months,47,1.3611352447
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,AS cohort entry to exposure,21,0.6081668115
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,12 months,71,2.0561830292
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,24 months,93,2.6933101651
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,36 months,100,2.8960324356
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,AS cohort entry to exposure,49,1.4190558934
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,12 months,28,0.810889082
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,24 months,35,1.0136113524
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,36 months,41,1.1873732986
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,AS cohort entry to exposure,24,0.6950477845
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,12 months,23,0.6660874602
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,24 months,35,1.0136113524
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,36 months,42,1.2163336229
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,AS cohort entry to exposure,19,0.5502461628
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,24 months,13,0.3764842166
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,36 months,13,0.3764842166
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,AS cohort entry to exposure,4,0.1158412974
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,12 months,104,3.011873733
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,24 months,156,4.5178105995
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,36 months,176,5.0970170866
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,AS cohort entry to exposure,79,2.2878656241
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,12 months,38,1.1004923255
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,24 months,51,1.4769765421
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,36 months,57,1.6507384883
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,AS cohort entry to exposure,29,0.8398494063
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,12 months,171,4.9522154648
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,24 months,194,5.618302925
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,36 months,201,5.8210251955
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,AS cohort entry to exposure,138,3.9965247611
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,12 months,102,2.9539530843
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,24 months,122,3.5331595714
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,36 months,132,3.8227628149
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,AS cohort entry to exposure,66,1.9113814075
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,12 months,1,0.0289603244
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,24 months,2,0.0579206487
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,36 months,2,0.0579206487
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,24 months,7,0.2027222705
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,36 months,7,0.2027222705
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,AS cohort entry to exposure,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,12 months,3,0.0868809731
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,24 months,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,36 months,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,12 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,24 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,36 months,5,0.1448016218
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,AS cohort entry to exposure,3,0.0868809731
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,12 months,26,0.7529684332
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,24 months,37,1.0715320012
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,36 months,41,1.1873732986
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,AS cohort entry to exposure,20,0.5792064871
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,24 months,1,0.0289603244
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,36 months,1,0.0289603244
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,12 months,6,0.1737619461
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,24 months,11,0.3185635679
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,36 months,16,0.4633651897
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,AS cohort entry to exposure,2,0.0579206487
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,12 months,14,0.405444541
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,24 months,23,0.6660874602
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,36 months,24,0.6950477845
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,AS cohort entry to exposure,7,0.2027222705
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,12 months,26,0.7529684332
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,24 months,58,1.6796988126
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,36 months,67,1.9403417318
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,AS cohort entry to exposure,22,0.6371271358
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,12 months,129,3.7358818419
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,24 months,168,4.8653344917
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,36 months,194,5.618302925
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,AS cohort entry to exposure,90,2.606429192
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,12 months,202,5.8499855198
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,24 months,242,7.0083984941
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,36 months,255,7.3848827107
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,AS cohort entry to exposure,163,4.72053287
Marketscan,TNF,Uveitis,Uveitis,2864,3453,12 months,259,7.5007240081
Marketscan,TNF,Uveitis,Uveitis,2864,3453,24 months,311,9.0066608746
Marketscan,TNF,Uveitis,Uveitis,2864,3453,36 months,339,9.8175499566
Marketscan,TNF,Uveitis,Uveitis,2864,3453,AS cohort entry to exposure,210,6.0816681147
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,12 months,25,1.481042654
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,24 months,29,1.7180094787
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,36 months,33,1.9549763033
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,AS cohort entry to exposure,24,1.4218009479
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,12 months,23,1.3625592417
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,24 months,39,2.3104265403
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,36 months,57,3.3767772512
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,AS cohort entry to exposure,20,1.1848341232
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,12 months,140,8.2938388626
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,24 months,172,10.18957346
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,36 months,200,11.848341232
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,AS cohort entry to exposure,117,6.9312796209
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,12 months,61,3.6137440758
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,24 months,102,6.0426540284
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,36 months,114,6.7535545024
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,AS cohort entry to exposure,66,3.9099526066
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,12 months,50,2.9620853081
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,24 months,74,4.3838862559
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,36 months,92,5.4502369668
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,AS cohort entry to exposure,49,2.9028436019
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,12 months,14,0.8293838863
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,24 months,23,1.3625592417
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,36 months,32,1.8957345972
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,AS cohort entry to exposure,16,0.9478672986
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,12 months,160,9.4786729858
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,24 months,262,15.521327014
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,36 months,330,19.549763033
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,AS cohort entry to exposure,229,13.566350711
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,12 months,53,3.1398104265
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,24 months,73,4.3246445498
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,36 months,84,4.9763033175
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,AS cohort entry to exposure,62,3.672985782
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,12 months,108,6.3981042654
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,24 months,117,6.9312796209
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,36 months,119,7.0497630332
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,AS cohort entry to exposure,102,6.0426540284
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,12 months,61,3.6137440758
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,24 months,73,4.3246445498
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,36 months,75,4.4431279621
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,AS cohort entry to exposure,70,4.1469194313
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,12 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,24 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,36 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,AS cohort entry to exposure,2,0.1184834123
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,12 months,4,0.2369668246
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,24 months,7,0.4146919431
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,36 months,7,0.4146919431
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,AS cohort entry to exposure,5,0.2962085308
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,12 months,6,0.355450237
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,24 months,9,0.5331753555
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,36 months,9,0.5331753555
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,AS cohort entry to exposure,5,0.2962085308
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,12 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,24 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,36 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,AS cohort entry to exposure,2,0.1184834123
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,12 months,13,0.7701421801
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,24 months,20,1.1848341232
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,36 months,27,1.5995260664
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,AS cohort entry to exposure,13,0.7701421801
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,12 months,62,3.672985782
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,24 months,82,4.8578199052
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,36 months,104,6.1611374408
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,AS cohort entry to exposure,72,4.2654028436
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,12 months,1,0.0592417062
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,24 months,1,0.0592417062
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,36 months,3,0.1777251185
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,AS cohort entry to exposure,3,0.1777251185
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,12 months,4,0.2369668246
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,24 months,7,0.4146919431
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,36 months,8,0.4739336493
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,AS cohort entry to exposure,4,0.2369668246
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,12 months,31,1.836492891
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,24 months,52,3.0805687204
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,36 months,70,4.1469194313
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,AS cohort entry to exposure,41,2.4289099526
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,12 months,49,2.9028436019
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,24 months,95,5.6279620853
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,36 months,119,7.0497630332
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,AS cohort entry to exposure,79,4.6800947867
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,12 months,65,3.8507109005
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,24 months,82,4.8578199052
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,36 months,100,5.9241706161
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,AS cohort entry to exposure,76,4.5023696682
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,12 months,93,5.509478673
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,24 months,115,6.8127962085
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,36 months,130,7.7014218009
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,AS cohort entry to exposure,100,5.9241706161
Medicare,DMARD,Uveitis,Uveitis,1432,1688,12 months,121,7.1682464455
Medicare,DMARD,Uveitis,Uveitis,1432,1688,24 months,151,8.9454976303
Medicare,DMARD,Uveitis,Uveitis,1432,1688,36 months,171,10.130331754
Medicare,DMARD,Uveitis,Uveitis,1432,1688,AS cohort entry to exposure,142,8.4123222749
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,12 months,69,1.663853388
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,24 months,76,1.8326501085
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,36 months,86,2.0737882807
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,AS cohort entry to exposure,82,1.9773330118
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,12 months,68,1.6397395708
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,24 months,107,2.5801784422
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,36 months,141,3.4000482276
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,AS cohort entry to exposure,76,1.8326501085
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,12 months,363,8.7533156499
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,24 months,458,11.044128286
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,36 months,524,12.635640222
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,AS cohort entry to exposure,416,10.031347962
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,12 months,168,4.0511212925
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,24 months,225,5.4256088739
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,36 months,264,6.3660477454
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,AS cohort entry to exposure,221,5.329153605
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,12 months,107,2.5801784422
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,24 months,158,3.8099831203
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,36 months,193,4.6539667229
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,AS cohort entry to exposure,193,4.6539667229
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,12 months,30,0.7234145165
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,24 months,48,1.1574632264
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,36 months,66,1.5915119363
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,AS cohort entry to exposure,52,1.2539184953
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,12 months,424,10.2242585
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,24 months,658,15.866891729
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,36 months,792,19.098143236
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,AS cohort entry to exposure,713,17.193151676
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,12 months,74,1.7844224741
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,24 months,128,3.0865686038
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,36 months,173,4.1716903786
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,AS cohort entry to exposure,129,3.110682421
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,12 months,131,3.1589100555
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,24 months,151,3.6411863998
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,36 months,162,3.9064383892
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,AS cohort entry to exposure,168,4.0511212925
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,12 months,64,1.5432843019
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,24 months,79,1.9049915602
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,36 months,95,2.2908126356
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,AS cohort entry to exposure,107,2.5801784422
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,12 months,4,0.0964552689
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,24 months,4,0.0964552689
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,36 months,4,0.0964552689
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,AS cohort entry to exposure,5,0.1205690861
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,12 months,7,0.1687967205
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,24 months,9,0.217024355
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,36 months,12,0.2893658066
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,AS cohort entry to exposure,19,0.4581625271
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,12 months,10,0.2411381722
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,24 months,12,0.2893658066
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,36 months,12,0.2893658066
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,AS cohort entry to exposure,9,0.217024355
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,12 months,2,0.0482276344
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,24 months,2,0.0482276344
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,36 months,2,0.0482276344
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,AS cohort entry to exposure,2,0.0482276344
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,12 months,11,0.2652519894
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,24 months,14,0.337593441
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,36 months,19,0.4581625271
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,AS cohort entry to exposure,23,0.554617796
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,12 months,116,2.7972027972
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,24 months,181,4.3646009163
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,36 months,225,5.4256088739
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,AS cohort entry to exposure,201,4.8468772607
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,12 months,6,0.1446829033
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,24 months,6,0.1446829033
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,36 months,7,0.1687967205
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,AS cohort entry to exposure,12,0.2893658066
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,12 months,10,0.2411381722
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,24 months,15,0.3617072583
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,36 months,22,0.5305039788
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,AS cohort entry to exposure,16,0.3858210755
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,12 months,143,3.4482758621
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,24 months,213,5.1362430673
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,36 months,241,5.8114299494
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,AS cohort entry to exposure,195,4.7021943574
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,12 months,147,3.5447311309
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,24 months,230,5.54617796
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,36 months,291,7.0171208102
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,AS cohort entry to exposure,280,6.7518688208
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,12 months,98,2.3631540873
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,24 months,139,3.3518205932
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,36 months,172,4.1475765614
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,AS cohort entry to exposure,168,4.0511212925
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,12 months,100,2.4113817217
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,24 months,136,3.2794791415
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,36 months,149,3.5929587654
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,AS cohort entry to exposure,172,4.1475765614
Medicare,NSAID,Uveitis,Uveitis,2755,4147,12 months,215,5.1844707017
Medicare,NSAID,Uveitis,Uveitis,2755,4147,24 months,295,7.1135760791
Medicare,NSAID,Uveitis,Uveitis,2755,4147,36 months,341,8.2228116711
Medicare,NSAID,Uveitis,Uveitis,2755,4147,AS cohort entry to exposure,339,8.1745840367
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,12 months,24,0.9642426677
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,24 months,33,1.3258336681
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,36 months,41,1.6472478907
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,AS cohort entry to exposure,3,0.1205303335
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,12 months,32,1.2856568903
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,24 months,49,1.9686621133
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,36 months,66,2.6516673363
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,12 months,262,10.526315789
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,24 months,312,12.535154681
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,36 months,353,14.182402571
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,AS cohort entry to exposure,16,0.6428284452
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,12 months,114,4.5801526718
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,24 months,155,6.2274005625
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,36 months,180,7.231820008
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,AS cohort entry to exposure,4,0.1607071113
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,12 months,81,3.2543190036
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,24 months,122,4.9015668943
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,36 months,155,6.2274005625
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,12 months,22,0.8838891121
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,24 months,43,1.7276014464
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,36 months,56,2.2498995581
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,12 months,189,7.5934110084
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,24 months,359,14.423463238
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,36 months,470,18.883085577
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,12 months,39,1.5668943351
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,24 months,60,2.4106066693
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,36 months,77,3.0936118923
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,AS cohort entry to exposure,2,0.0803535556
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,12 months,147,5.9059863399
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,24 months,165,6.6291683407
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,36 months,174,6.9907593411
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,AS cohort entry to exposure,36,1.4463640016
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,12 months,63,2.5311370028
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,24 months,80,3.2141422258
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,36 months,93,3.7364403375
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,AS cohort entry to exposure,11,0.441944556
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,12 months,3,0.1205303335
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,24 months,4,0.1607071113
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,36 months,5,0.2008838891
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,12 months,2,0.0803535556
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,24 months,6,0.2410606669
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,36 months,8,0.3214142226
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,12 months,7,0.2812374448
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,24 months,8,0.3214142226
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,36 months,8,0.3214142226
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,12 months,1,0.0401767778
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,24 months,1,0.0401767778
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,36 months,1,0.0401767778
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,12 months,9,0.3615910004
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,24 months,14,0.5624748895
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,36 months,16,0.6428284452
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,12 months,70,2.8123744476
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,24 months,101,4.0578545601
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,36 months,132,5.3033346726
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,12 months,6,0.2410606669
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,24 months,9,0.3615910004
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,36 months,11,0.441944556
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,12 months,6,0.2410606669
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,24 months,8,0.3214142226
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,36 months,10,0.4017677782
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,AS cohort entry to exposure,0,0
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,12 months,68,2.7320208919
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,24 months,112,4.4997991161
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,36 months,146,5.8658095621
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,AS cohort entry to exposure,6,0.2410606669
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,12 months,70,2.8123744476
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,24 months,120,4.8212133387
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,36 months,157,6.3077541181
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,AS cohort entry to exposure,2,0.0803535556
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,12 months,65,2.6114905585
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,24 months,94,3.7766171153
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,36 months,109,4.3792687826
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,AS cohort entry to exposure,4,0.1607071113
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,12 months,94,3.7766171153
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,24 months,116,4.6605062274
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,36 months,125,5.0220972278
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,AS cohort entry to exposure,27,1.0847730012
Medicare,No exposure,Uveitis,Uveitis,2489,2489,12 months,153,6.1470470068
Medicare,No exposure,Uveitis,Uveitis,2489,2489,24 months,196,7.8746484532
Medicare,No exposure,Uveitis,Uveitis,2489,2489,36 months,219,8.7987143431
Medicare,No exposure,Uveitis,Uveitis,2489,2489,AS cohort entry to exposure,30,1.2053033347
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,12 months,19,0.5813953488
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,24 months,30,0.9179926561
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,36 months,37,1.1321909425
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,AS cohort entry to exposure,15,0.458996328
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,12 months,35,1.0709914321
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,24 months,55,1.6829865361
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,36 months,71,2.1725826193
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,AS cohort entry to exposure,35,1.0709914321
Medicare,TNF,Cancer,Solid Cancer,2660,3268,12 months,170,5.2019583843
Medicare,TNF,Cancer,Solid Cancer,2660,3268,24 months,216,6.6095471236
Medicare,TNF,Cancer,Solid Cancer,2660,3268,36 months,248,7.5887392901
Medicare,TNF,Cancer,Solid Cancer,2660,3268,AS cohort entry to exposure,135,4.1309669523
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,12 months,90,2.7539779682
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,24 months,129,3.9473684211
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,36 months,147,4.4981640147
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,AS cohort entry to exposure,83,2.5397796818
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,12 months,80,2.4479804162
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,24 months,110,3.3659730722
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,36 months,130,3.9779681763
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,AS cohort entry to exposure,58,1.7747858017
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,12 months,18,0.5507955936
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,24 months,33,1.0097919217
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,36 months,44,1.3463892289
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,AS cohort entry to exposure,32,0.9791921665
Medicare,TNF,Infection,Hospitalized infection,2660,3268,12 months,245,7.4969400245
Medicare,TNF,Infection,Hospitalized infection,2660,3268,24 months,428,13.096695226
Medicare,TNF,Infection,Hospitalized infection,2660,3268,36 months,530,16.217870257
Medicare,TNF,Infection,Hospitalized infection,2660,3268,AS cohort entry to exposure,270,8.2619339045
Medicare,TNF,Infection,Opportunistic infection,2660,3268,12 months,89,2.723378213
Medicare,TNF,Infection,Opportunistic infection,2660,3268,24 months,135,4.1309669523
Medicare,TNF,Infection,Opportunistic infection,2660,3268,36 months,164,5.0183598531
Medicare,TNF,Infection,Opportunistic infection,2660,3268,AS cohort entry to exposure,99,3.029375765
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,12 months,239,7.3133414933
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,24 months,265,8.1089351285
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,36 months,276,8.4455324357
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,AS cohort entry to exposure,226,6.9155446756
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,12 months,99,3.029375765
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,24 months,126,3.8555691554
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,36 months,140,4.2839657283
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,AS cohort entry to exposure,104,3.182374541
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,12 months,6,0.1835985312
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,24 months,10,0.305997552
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,36 months,10,0.305997552
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,AS cohort entry to exposure,6,0.1835985312
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,12 months,5,0.152998776
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,24 months,9,0.2753977968
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,36 months,12,0.3671970624
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,AS cohort entry to exposure,11,0.3365973072
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,12 months,6,0.1835985312
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,24 months,13,0.3977968176
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,36 months,14,0.4283965728
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,AS cohort entry to exposure,5,0.152998776
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,12 months,8,0.2447980416
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,24 months,20,0.611995104
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,36 months,25,0.76499388
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,AS cohort entry to exposure,14,0.4283965728
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,12 months,78,2.3867809058
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,24 months,132,4.0391676867
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,36 months,160,4.8959608323
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,AS cohort entry to exposure,105,3.2129742962
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,12 months,5,0.152998776
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,24 months,7,0.2141982864
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,36 months,8,0.2447980416
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,AS cohort entry to exposure,2,0.0611995104
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,12 months,9,0.2753977968
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,24 months,12,0.3671970624
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,36 months,16,0.4895960832
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,AS cohort entry to exposure,7,0.2141982864
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,12 months,51,1.5605875153
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,24 months,100,3.0599755202
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,36 months,116,3.5495716034
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,AS cohort entry to exposure,65,1.9889840881
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,12 months,73,2.2337821297
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,24 months,133,4.0697674419
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,36 months,172,5.2631578947
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,AS cohort entry to exposure,113,3.4577723378
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,12 months,177,5.4161566707
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,24 months,217,6.6401468788
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,36 months,237,7.2521419829
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,AS cohort entry to exposure,169,5.1713586291
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,12 months,223,6.82374541
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,24 months,269,8.2313341493
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,36 months,293,8.9657282742
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,AS cohort entry to exposure,227,6.9461444308
Medicare,TNF,Uveitis,Uveitis,2660,3268,12 months,279,8.5373317013
Medicare,TNF,Uveitis,Uveitis,2660,3268,24 months,345,10.556915545
Medicare,TNF,Uveitis,Uveitis,2660,3268,36 months,399,12.209302326
Medicare,TNF,Uveitis,Uveitis,2660,3268,AS cohort entry to exposure,296,9.0575275398
